CYTK vs BBIO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 01, 2026

CYTK

59.7
AI Score
VS
CYTK Wins

BBIO

55.7
AI Score

Investment Advisor Scores

CYTK

60score
Recommendation
HOLD

BBIO

56score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric CYTK BBIO Winner
Revenue 19.36M 194.51M BBIO
Net Income -206.03M -166.56M BBIO
Net Margin -1064.5% -85.6% BBIO
Operating Income -183.62M -105.96M BBIO
ROE 24.9% 7.3% CYTK
ROA -16.2% -12.1% BBIO
Total Assets 1.27B 1.37B BBIO
Cash 129.84M 879.89M BBIO
Debt/Equity -0.30 -1.16 BBIO
Current Ratio 4.21 1.52 CYTK
Free Cash Flow -151.39M -197.35M CYTK

Relative Price Performance (Last 90 Days)

CYTK 1M: -9.5% · 3M: +20.6% BBIO 1M: +7.5% · 3M: +12.6%

Current Technical Phase

CYTK

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 41

RSI (14): 41.4 · Price: $77.13

BBIO

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (7.8% over 20 days), RSI 51

RSI (14): 50.8 · Price: $80.09

Fundamentals Snapshot

Metric CYTK BBIO
Market Cap
Forward P/E -16.5 140.8
Trailing P/E
Revenue (TTM)
Revenue Growth 11.3% 0.7%
Gross Margin -2.9% 1.0%
Operating Margin -9.5% -0.5%
EPS -7.03 -3.67
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, CYTK is currently the stronger investment candidate, winning 3 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.